Chemical Compound
Acetamide, N-[[(5S)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]-; N-{[(S)-3-(3-Fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl]methyl}acetamide;Acetamide, N-[[3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]-, (S)-; (S)-Linezolid; Averozolid; Linezolid; Linospan; Linox; Lizoforce; Lizolid; N-[[(5S)-3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide; N-[[(5S)-3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide; PNU 100766; U 100766; Zyrox; Zyvox; Zyvoxid
CAS Registry Number
165800-03-3
Primary record
Acetamide, N-[[(5S)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]-; N-{[(S)-3-(3-Fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl]methyl}acetamide;Acetamide, N-[[3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]-, (S)-; (S)-Linezolid; Averozolid; Linezolid; Linospan; Linox; Lizoforce; Lizolid; N-[[(5S)-3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide; N-[[(5S)-3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide; PNU 100766; U 100766; Zyrox; Zyvox; Zyvoxid
- 库存
- 6,033 克
- 纯度
- 99.2 %
- CAS
- 165800-03-3
化合物标识与属性
- CAS
- 165800-03-3
- PubChem CID
- 441401
- SMILES
- CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F
- Canonical SMILES
- CC(=O)NC[C@H]1CN(c2ccc(N3CCOCC3)c(F)c2)C(=O)O1
名称与同义词
- linezolid
- Zyvox
- 165800-03-3
- Zyvoxid
- Zyvoxam
- Linezlid
- Zivoxid
- Zyvoxa
- linospan
- linox
- Linezolidum
- Linezoid
- LINEZOLIDE
- Zybox
- Linezolid RS
- PNU-100766
- Zyvox (TN)
- Linezolid (Zyvox)
- (-)-Linezolid
- Linezolid [USAN:INN]
- Zyvoxam (TN)
- Zyvoxid (TN)
- FLOSEQUINAN
- C16H20FN3O4
- Linezolid (Standard)
- PNU 100766
- ISQ9I6J12J
- RefChem:5949
- Linezolid & VRC3375
- CHEMBL126
- LINEZOLID [INN]
- LINEZOLID [JAN]
- UNII-ISQ9I6J12J
- LINEZOLID [MI]
- linezolid sodium chloride
- LINEZOLID [HSDB]
- LINEZOLID [USAN]
- U-100766
- LINEZOLID [VANDF]
- (S)-N-((3-(3-fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl)methyl)acetamide
- LinezolidPNU-100766
- DTXSID5046489
- Linezolid (JAN/USAN/INN)
- Linezolid [USAN:INN:BAN]
- MFCD00937825
- D07UYO
- LINEZOLID [MART.]
- HSDB 7478
- AC1L9B3M
- LINEZOLID [USP-RS]
- LINEZOLID [WHO-DD]
- SCHEMBL5027
- TYZROVQLWOKYKF-ZDUSSCGKSA-N
- DTXCID3026489
- Linezolid (1367561)
- cc-154
- CHEBI:63607
- MLS000759444
- MLS001424075
- BIDD:GT0404
- U 100766
- Benzotriazol-2-yl-acetonitrile
- PNU100766
- cid_441401
- Linezolid (PNU-100766)
- orb1310657
- QCR-88
- SCHEMBL7992562
- LINEZOLID [ORANGE BOOK]
- Linezolid, >=98% (HPLC)
- GTPL10827
- J01XX08
- LINEZOLID [USP MONOGRAPH]
- SYN3021
- GLXC-04742
- HMS2051F08
- HMS2089K06
- HMS3260C14
- HMS3713K10
- Linezolid, 98% - 10mg 10mg
- BCP05586
- KS-00000BB5
- MSK14235
- ZINC2008866
- Tox21_112246
- Tox21_500096
- BBF-04161
- BDBM50116067
- C16-H20-F-N3-O4
- CID441401
- EBC-08517
- HB4443
- HY-10394R
- s1408
- 111GE017
- CPD000466335
- NDA 21-130 Zyvox (linezolid tablets)
- AKOS016340522
- U-100,766
- ACN-028794
- AF58050
- AM84567
- BCP9000855
- CCG-101009
- CID:441401
- CS-0756
- CS-O-30960
- DB00601
- KS-1178
- NC00259
- Acetamide, N-[[(5S)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]-
- Linezolid 100 microg/mL in Acetonitrile
- NCGC00164628-01
- NCGC00260781-01
- NCGC00263531-03
- NCGC00263531-05
- NCGC00263531-10
- AJ-32488
- AN-15409
- CJ-07345
- HY-10394
- SAM001246624
- SC-11638
- SMR000466335
- SY056734
- SID:283537558
- AB0012049
- J709.722K
- LS-173594
- N-(((S)-3-(3-Fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl)methyl)acetamide
- ST2408359
- TL8001272
- A5181
- CAS-165800-03-3
- L0362
- N-[[(5S)-3-(3-fluoro-4-morpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide
- NS00008464
- SW197639-3
- U100766
- A10533
- C08146
- D00947
- J90009
- M-8338
- 100766, U
- AB00639994-06
- AB00639994-08
- AB00639994-09
- AB00639994_10
- AB00639994_11
- 800L033
- A810662
- C098010
- F227724
- N-[[(5S)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide
- NDA 21-131 Zyvox for injection (linezolid injection)
- Q411377
- SR-01000759376
- N-((3-(3-fluoro-4-morpholinylphenyl)-2-oxo-5-oxazolidinyl)methyl)acetamide
- SR-01000759376-4
- SR-01000759376-5
- BRD-K66876909-001-11-8
- BRD-K66876909-001-12-6
- NDA 21-132 Zyvox oral suspension (linzolid oral suspension)
- SR-01000759376-11
- (S)-N-[[3-(3-Fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl]methyl]acetamide
- (S)-N-[[3-(3-fluoro-4-morpholinylphenyl)-2-oxo-5-oxazolidinyl]methyl]acetamide
- D000069349
- PNU-100766, U-100766, Zyvoxid, Zyvoxam, Linezolid
- Z1515385084
- Acetamide, N-((3-(3-fluoro-4-(4-morpholinyl)phenyl)-2-oxo-5-oxazolidinyl)methyl)-, (S)-
- N-[[(5S)-3-(3-fluoro-4-morpholino-phenyl)-2-oxo-oxazolidin-5-yl]methyl]acetamide
- N-{[(5s)-3-(3-Fluoro-4-Morpholin-4-Ylphenyl)-2-Oxo-1,3-Oxazolidin-5-Yl]methyl}acetamide
- LINEZOLID IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
- Linezolid, United States Pharmacopeia (USP) Reference Standard
- ZLD
- Acetamide, N-(((5S)-3-(3-fluoro-4-(4-morpholinyl)phenyl)-2-oxo-5-oxazolidinyl)methyl)-
- N-({(5S)-3-[3-fluoro-4-(morpholin-4-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl)acetamide
- N-[[(5S)-3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]-acetamide
- N-{[(5S)-3-[3-fluoro-4-(morpholin-4-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl}acetamide
- (S)-N-((3-fluoro-4-morpholinophenyl)-2-oxaoxazolidin-5-yl)methyl)acetamide
- Linezolid, Pharmaceutical Secondary Standard; Certified Reference Material
- N-({5S)-3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl)acetamide, N-[[(S)-3-(3-Fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl]methyl]acetamide
- (5S)-3-(3-Fluoro-4-morpholinophenyl)-5alpha-(acetylaminomethyl)oxazolidine-2-one
- (5S)-5-(Acetylaminomethyl)-3-(3-fluoro-4-morpholinophenyl)-2-oxazolidinone
- (Linezolid)N-[3-(3-Fluoro-4-morpholin-4-yl-phenyl)-2-oxo-oxazolidin-5-ylmethyl]-acetamide
- (R)-N-((3-(3-fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl)methyl)acetamide
- (S)-N-((3-(3-fluoro-4-(4-morpholinyl)phenyl)-2-oxo-5-oxazolidinyl)methyl)acetamide
- (S)-N-[ [3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-oxazolidin-5-yl]methyl]-acetamide
- (S)-N-[[3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]-acetamide
- Acetamide, N-[[3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]-, (S)-
- N-(((5S)-3-(3-fluoro-4-morpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl)methyl)acetamide
- N-(((5S)-3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl)methyl)-acetamide
- N-[(R)-3-(3-Fluoro-4-morpholin-4-yl-phenyl)-2-oxo-oxazolidin-5-ylmethyl]-acetamide
- N-[(S)-3-(3-Fluoro-4-morpholin-4-yl-phenyl)-2-oxo-oxazolidin-5-ylmethyl]-acetamide
- N-[[(5S)-2-Oxo-3-(3-fluoro-4-morpholinophenyl)-5alpha-oxazolidinyl]methyl]acetamide
- N-[[(5S)-3-(3-Fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl]methyl]acetamide
- N-[[(5S)-3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl] methyl] acetamide
- N-[[(S)-3-(3-Fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl]methyl]acetamide
- N-[[3-(3-Fluoro-4-morpholinophenyl)-2-oxooxazolidin-5alpha-yl]methyl]acetamide
- N-[3-(3-Fluoro-4-morpholin-4-yl-phenyl)-2-oxo-oxazolidin-5-ylmethyl]-acetamide
- N-[3-(3-Fluoro-4-morpholin-4-yl-phenyl)-2-oxo-oxazolidin-5-ylmethyl]-acetamide(linezolid)
- (S)-3-(3-Fluoro-4-morpholin-4-yl-phenyl)-5-[(1-hydroxy-ethylamino)-methyl]-oxazolidin-2-one
- Acetamide, N-[[(5S)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]-; N-{[(S)-3-(3-Fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl]methyl}acetamide;Acetamide, N-[[3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]-, (S)-; (S)-Linezolid; Averozolid; Linezolid; Linospan; Linox; Lizoforce; Lizolid; N-[[(5S)-3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide; N-[[(5S)-3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide; PNU 100766; U 100766; Zyrox; Zyvox; Zyvoxid
- LZD
- N-(((5S)-3-(3-fluoro-4-(morpholin-4-yl)phenyl)-2-oxo-1,3-oxazolidin-5-yl)methyl)acetamide
- N-((S)-2-oxo-3-(S)-2,3,3a,4-tetrahydro-1H-benzo[b]pyrrolo[1,2-d][1,4]oxazin-7-yl-oxazolidin-5-ylmethyl)-acetamide